Please login or register first to view this content.
OB/GYN Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Zulresso Indication Expanded to Include Younger Patients With Postpartum Depression
Post Hoc Analysis Shows Phexxi Prevented 99% of Pregnancies Per Act of Intercourse
Fezolinetant Cuts Vasomotor Symptoms in Menopause
Women With PCOS Report More Morbidity, Medication Use
FDA to Review Data on Long-Term Use of Myfembree for Uterine Fibroids
FDA Extends Shelf Life of On-Demand Contraceptive Phexxi
Trial Evaluating Zuranolone for Postpartum Depression Meets All Endpoints
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
Counseling, Provision Interventions Increase Contraceptive Use
At-Home Test Helps With Birth Control Selection by Identifying Risk for Side Effects
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Annovera Product Supply Expected to Increase Following FDA Approval
Beyond Hysterectomy: Increasing Awareness of Uterine Fibroids and New Treatment Options
Serotonergic Antidepressants in Pregnancy Not Tied to Neonatal Seizures
FDA Extends Review Period for Relugolix Combo Therapy for Endometriosis Pain
April 2022: Notable Drug Approvals
Supreme Court Set to Overturn Roe vs Wade, Leaked Draft Opinion Shows
Vivjoa Approved for Recurrent Vulvovaginal Candidiasis
